Aventis Wants Sens.' Letter Excluded In Arava Case
Sanofi-Aventis U.S. LLC and Aventis Pharmaceuticals Inc. are asking the judge overseeing a lawsuit accusing them of blocking generic competition for arthritis drug Arava not to allow a 2006 letter penned...To view the full article, register now.
Already a subscriber? Click here to view full article